Nephrocare Health Services Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Please find attached herewith Press Release of the Financial Results for the quarter ended 31st December 2025.".
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nephrocare Health Services Limited has shared a press release dated February 10, 2026 with the stock exchange, covering its financial results for the third quarter of FY26 (quarter ended 31 December 2025). The filing is essentially a regulatory disclosure attaching the press release rather than the detailed financial figures themselves. Investors would need to look at the attached press release or the separately filed financial results for the actual revenue, profit, and margin numbers. No specific financial highlights or surprises have been mentioned in the headline.
This is a routine procedural filing that confirms the company has formally released its Q3 FY26 results. The real impact on the stock will depend on the actual numbers in the attached press release, which are not visible from this headline alone.